Search results for "030211 gastroenterology & hepatology"

showing 10 items of 1275 documents

Factores predictores de mortalidad y estrategias de detección precoz de síndrome hepatopulmonar en pacientes trasplantados hepáticos

2016

ResumenIntroducciónEl síndrome hepatopulmonar (SHP) es una enfermedad grave y progresiva cuya fisiopatología reside en un shunt intrapulmonar con hipoxia y deterioro clínico severo. Como único tratamiento efectivo se ha postulado el trasplante hepático (TH), en pacientes adecuadamente seleccionados.ObjetivoReconocer la importancia del diagnóstico temprano del SHP.Pacientes y métodosMediante un estudio observacional, descriptivo, con carácter retrospectivo de 8 pacientes con SHP, a los que se les realizó TH en el período entre abril del 2006 y agosto del 2014. Se han revisado los datos clínicos previos al trasplante y el seguimiento tras este.Se empleó un estudio multivariante (stepwise forw…

Transplante de hígadoLiver transplantationInsuficiencia hepáticaHepatopulmonary syndrome030230 surgeryCritical Care and Intensive Care MedicineAnestesia03 medical and health sciences0302 clinical medicineAnesthesiology and Pain MedicineSíndrome hepatopulmonarMortalidadHepatic insufficiency030211 gastroenterology & hepatologyAnesthesiaMortalityRevista Colombiana de Anestesiología
researchProduct

2018

Celiac disease is a small intestinal inflammatory disease with autoimmune features that is triggered and maintained by the ingestion of the storage proteins (gluten) of wheat, barley, and rye. Prevalence of celiac disease is increased in patients with mono- and/or polyglandular autoimmunity and their relatives. We have reviewed the current and pertinent literature that addresses the close association between celiac disease and endocrine autoimmunity. The close relationship between celiac disease and glandular autoimmunity can be largely explained by sharing of a common genetic background. Further, between 10 and 30% of patients with celiac disease are thyroid and/or type 1 diabetes antibody…

Type 1 diabetesNutrition and Dieteticsbiologybusiness.industryTissue transglutaminaseGraves' diseaseThyroidnutritional and metabolic diseases030209 endocrinology & metabolismDiseasemedicine.disease_causemedicine.diseasedigestive system diseasesAutoimmunity03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureImmunologybiology.proteinMedicine030211 gastroenterology & hepatologyGluten freeHashimoto DiseasebusinessFood ScienceNutrients
researchProduct

The “caput medusae” sign in portal hypertension

2018

Umbilical Veinsmedicine.medical_specialtyUrology030218 nuclear medicine & medical imagingDiagnosis DifferentialVaricose Veins03 medical and health sciences0302 clinical medicineX ray computedInternal medicineHypertension PortalmedicineHumansRadiology Nuclear Medicine and imagingPortal hypertensionRadiological and Ultrasound Technologymedicine.diagnostic_testPortal Veinbusiness.industryGastroenterologyMagnetic resonance imagingHepatologymedicine.diseaseMagnetic Resonance ImagingPortal hypertension030211 gastroenterology & hepatologyRadiologymedicine.symptomTomography X-Ray ComputedbusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaCaput medusaeMRICT
researchProduct

Uncommon evolutions and complications of common benign liver lesions

2018

International audience; Frequently encountered on abdominal imaging studies, the majority of common benign liver lesions are asymptomatic, confidently diagnosed by imaging, and do not require further workup, follow-up, or treatment. The increasing use of multimodality liver imaging, has allowed the recognition of uncommon evolutions of common benign liver lesions such as size changes, fibrotic regression, and content and vascularization changes, and their complications such as rupture, hemorrhage, thrombosis, extrinsic compression, and malignancy. The purpose of this pictorial review is to describe and illustrate the incidence and diagnostic features of these uncommon evolutions and complic…

Uncommon evolutionsmedicine.medical_specialtyBenign liver lesionComplications[SDV]Life Sciences [q-bio]UrologyComputed tomographyMalignancyAsymptomaticExtrinsic compression03 medical and health sciences0302 clinical medicineInternal medicinemedicineBenign liver lesionsHumansRadiology Nuclear Medicine and imagingComputed tomographyRadiological and Ultrasound Technologymedicine.diagnostic_testbusiness.industryLiver DiseasesLiver NeoplasmsGastroenterologyMagnetic resonance imagingHepatologymedicine.diseaseMagnetic Resonance ImagingThrombosis3. Good healthLiver030220 oncology & carcinogenesis030211 gastroenterology & hepatologyRadiologyDifferential diagnosismedicine.symptomTomography X-Ray ComputedbusinessComplicationUncommon evolutionAbdominal Radiology
researchProduct

Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.

2018

Nonalcoholic fatty liver disease (NAFLD) affects 25% of the global adult population with a range of 13.5% in Africa and 31.8% in the Middle East. Nonalcoholic fatty liver disease is closely associated with a constellation of metabolic comorbidities which include: obesity, type 2 diabetes mellitus, hypertension, and hypercholesteremia. In fact, the increasing number of metabolic comorbidities not only increases the prevalence of NAFLD but also places patients at higher risk for progressive liver disease. As such, NAFLD is presently among the top etiologies for hepatocellular carcinoma and an indication for liver transplantation (LT) in the United States. Therefore, the following recommendati…

United StateLiver Cirrhosismedicine.medical_specialtyCarcinoma HepatocellularTissue and Organ ProcurementWaiting ListsLiver Cirrhosimedicine.medical_treatmentComorbidity030230 surgeryLiver transplantationdigestive system03 medical and health sciencesLiver disease0302 clinical medicineNon-alcoholic Fatty Liver DiseaseRisk FactorsInternal medicineEpidemiologyNonalcoholic fatty liver diseasePrevalenceMedicineHumansMetabolic SyndromeTransplantationbusiness.industryRisk FactorIncidencePatient SelectionLiver Neoplasmsnutritional and metabolic diseasesType 2 Diabetes Mellitusmedicine.diseaseComorbidityObesitydigestive system diseasesUnited StatesLiver TransplantationLiver NeoplasmWaiting ListDisease Progression030211 gastroenterology & hepatologyMetabolic syndromebusinessHumanTransplantation
researchProduct

Efficacy and tolerability of a fixed dose combination of cortex phospholipid liposomes and cyanocobalamin for intramuscular use in peripheral neuropa…

2019

Peripheral neuropathies are frequently encourtered in clinical practice and are assiociated with a major impairment in quality of life . Howewvwr, their management reamans poor, and current therapies are often burdened with major side effects and can present poor efficacy on pain and functionality. Therefore, it has been suggested that the combination of two or more different drugs may improve analgesis efficacy and reduce side effects. Tricortin 1000 is formulated with 12 mg of Brain cortex phospholipid liposomes + 1000 microgrammi of Cyanocobalamin injectable (PL+ CNCb1) for intramuscolar use and is indicated in the tratment of poly-algo-neuropathic syndromes. This combination exerts a ma…

Viitamin B 12Fixed-dose combinationAnalgesicPharmacologyInjections IntramuscularInjections03 medical and health sciences0302 clinical medicinePharmacotherapyPeripheral nervous system diseasemedicineHumansCyanocobalaminphospholipidPhospholipidsCerebral CortexIntramuscularAnalgesicsClinical Trials as TopicNeck painLiposomebiologybusiness.industrySettore MED/34 - Medicina Fisica E RiabilitativaBack painPeripheral Nervous System DiseasesGeneral MedicineBack pain; Liposomes; Neuralgia; Peripheral nervous system diseases; Phospholipids; Vitamin B 12; Analgesics; Cerebral Cortex; Clinical Trials as Topic; Drug Combinations; Humans; Injections Intramuscular; Liposomes; Neuroprotective Agents; Peripheral Nervous System Diseases; Phospholipids; Vitamin B 12Drug CombinationsVitamin B 12Neuroprotective AgentsTolerability030220 oncology & carcinogenesisLiposomesbiology.proteinNeuralgia030211 gastroenterology & hepatologyIiposomemedicine.symptombusinessNeurotrophinMinerva Medica
researchProduct

Global prevalence and genotype distribution of hepatitis C virus infection in 2015:a modelling study

2017

WOS: 000426979400014

Viremia/epidemiologyPopulation ageingmedicine.medical_specialtyCIENCIAS MÉDICAS Y DE LA SALUDDelphi TechniqueGenotypeVoxilaprevirGenotype Global Health Hepatitis C Eradication Modelling studyMedicina Clínicaddc:616.07Global HealthBioinformatics03 medical and health sciences0302 clinical medicineCost of IllnessEpidemiologyJournal ArticlemedicineGlobal healthPrevalenceHumansViremia030212 general & internal medicineDisease EradicationDisease burdenddc:616HepatologyHepatitis C Chronic/epidemiologybusiness.industryGastroenterologyHepatitis CGlecaprevirHepatitis C Chronicmedicine.diseaseViremia/epidemiology/geneticsPibrentasvirGlobal Health/statistics & numerical dataHCVHEPATITIS C030211 gastroenterology & hepatologyMedicina Critica y de EmergenciaHuman medicinebusinessChronic/epidemiology/genetics/prevention & controlDemography
researchProduct

Burden of HIV and hepatitis C co-infection: the changing epidemiology of hepatitis C in HIV-infected patients in France.

2015

Équipe UB/CHU (EA) Pôle MERS CT3 Hors Enjeu; International audience; Background & AimsTo better evaluate the HIV-HCV co-infection burden in the context of new effective HCV treatment. MethodsWe reviewed all the epidemiological data available on HCV-related disease in HIV-infected patients in France. Sources of data have been selected using the following criteria: (i) prospective cohorts or cross-sectional surveys; (ii) conducted at a national level; (iii) in the HIV-infected population; (iv) able to identify HCV co-infection and chronic active hepatitis C (HCV RNA positive); and (v) conducted during the period 2003-2012. ResultsThe overall prevalence of HIV-HCV co-infection has decreased fr…

[SDE] Environmental SciencesMalemedicine.medical_specialty[SDV]Life Sciences [q-bio]PopulationContext (language use)HIV InfectionsDiseaseHistory 21st CenturyMen who have sex with menDrug Users03 medical and health sciences0302 clinical medicineInternal medicineAntiretroviral Therapy Highly ActiveEpidemiologyGenotypemedicinePrevalence[SDV.BV]Life Sciences [q-bio]/Vegetal BiologyHumans[SDV.BV] Life Sciences [q-bio]/Vegetal Biology030212 general & internal medicineHomosexuality Maleeducationeducation.field_of_studyHepatologybusiness.industryCoinfectionvirus diseasesHIVHepatitis Cmedicine.diseaseHepatitis C3. Good health[SDV] Life Sciences [q-bio]ImmunologyHCV[SDE]Environmental Sciences030211 gastroenterology & hepatologyepidemiologyFrancebusinessViral loadLiver international : official journal of the International Association for the Study of the Liver
researchProduct

Malignant transformation of presacral mass in Currarino syndrome

2019

International audience

[SDV.MHEP.HEM] Life Sciences [q-bio]/Human health and pathology/Hematologymedicine.medical_specialtybusiness.industry[SDV.CAN]Life Sciences [q-bio]/Cancer[SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/HematologyHematologymedicine.diseaseMalignant transformation03 medical and health sciences0302 clinical medicine[SDV.CAN] Life Sciences [q-bio]/CancerOncology030220 oncology & carcinogenesisPediatrics Perinatology and Child HealthPresacral massMedicine030211 gastroenterology & hepatologyRadiologybusinessCurrarino syndromeComputingMilieux_MISCELLANEOUS
researchProduct

Les hypertriglycéridémies à l’origine de pancréatite aiguë

2020

Resume La pancreatite aigue secondaire aux hypertriglyceridemies est en constante augmentation, et est vraisemblablement plus grave que les pancreatites aigues d’autres origines. Il convient donc de connaitre les caracteristiques specifiques, ainsi que les facteurs de risque associes a cette pancreatite, afin de pouvoir la reperer precocement. Un diagnostic precis permet un traitement specifique de l’episode, avec parfois necessite de recourir a la plasmapherese. Determiner l’etiologie de l’hypertriglyceridemie est primordial afin de pouvoir la prendre en charge de facon optimale, et ainsi diminuer la survenue des pancreatites aigues.

[SDV] Life Sciences [q-bio]03 medical and health sciences0302 clinical medicineNutrition and Dietetics[SDV]Life Sciences [q-bio]Endocrinology Diabetes and MetabolismInternal Medicine030211 gastroenterology & hepatology030204 cardiovascular system & hematologyCardiology and Cardiovascular MedicineMédecine des Maladies Métaboliques
researchProduct